The New York Entrepreneur

Novocure’s stock surges after positive results in brain-cancer trial

Read Time:10 Second

Novocure Ltd.’s stock soared 15% Wednesday after the company announced positive results from a late-stage trial of a medtech device to treat patients with lung cancer that has spread to their brains.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post The bitcoin halving is near. Here’s one thing for investors to keep in mind.
Next post Discover CEO resigns to take top job at Ally Financial